RES - O11 Project

Res-O11 is an innovative therapeutic technology designed to provide a novel treatment option for patients with hypercapnia (elevated blood carbon dioxide levels). Unlike conventional approaches that rely solely on the lungs for carbon dioxide elimination, Res-O11 utilizes the human gastrointestinal tract as an alternative pathway for CO₂ removal, offering a groundbreaking method to help restore carbon dioxide balance.

This first-in-class approach has the potential to benefit patients with chronic respiratory diseases and other conditions associated with impaired CO₂ clearance. By leveraging the gut as a natural route for carbon dioxide elimination, Res-O11 aims to complement existing respiratory therapies, improve patient outcomes, and expand treatment possibilities for hypercapnia management.